Uncommon Bio Stock
Uncommon Bio (previously Higher Steaks) is a biotechnology company leveraging cellular agriculture and biomanufacturing to develop therapeutics, following a strategic pivot from cultivated meat production. Originally focused on developing cultivated pork, the company’s meat platform was acquired by Meatable in 2025, allowing Uncommon Bio to focus exclusively on scalable biotechnologies for human health applications.
For more Uncommon Bio stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Uncommon Bio Company Overview
null
Management Team
| Benjamina Bollag Co-Founder and Chief Executive Officer |
| Ruth Faram Co-Founder and Chief Scientific Officer |
